Jenike MA: Handbook of Geriatric Psychopharmacology. Littleton, Mass , PSG Publishing Co, Inc. 1985 .
2.
Granacher RP , Baldessarini RJ: The usefulness of physostigmine in neurology and psychiatry in Klawans HL (ed): Clinical Neuropharmacology . New York, Raven Press, 1976, vol 1.
3.
Lipowski ZJ: Delirium. Springfield, Ill, Charles C. Thomas Publisher, 1980.
4.
Bartus AJ, Dean RL, Beer R., et al: The cholinergic hypothesis of geriatric memory dysfunction. Science1982;217:408-416.
5.
Drachman DA, Noffsinger D., Sahakian DJ, et al: Aging, memory and the cholinergic nervous system: A study of dichotic listening. Neurobiol Aging1980;1:39-45.
6.
Tune L., Coyle JT: Serum levels of anticholinergic drugs in treatment of acute extrapyramidal side effects. Arch Gen Psychiatry1980;37:293-297.
7.
Jenike MA: Monoamine oxidase inhibitors as treatment for depressed patients with primary degenerative dementia. Am J Psychiatry1985 ;142:763-764.
8.
Jenike MA; Alzheimer's disease. Sci Am Med1986 ;9:1-4.
9.
Rovner BW, David A., Lucas-Blaustein MJ, et al: Self-care capacity and anticholinergic drug levels in nursing home patients. Am J Psychiatry1988;145:107-109.
10.
Folstein M. , Folstein S., McHugh PR: Mini-Mental State: A practical method for grading the cognitive state of patients for the clinician . J Psychiatr Res1975;12:289-298.
11.
Wilkinson IM , Graham-White J.: Psychogeriatric Dependency Rating Scales (PGDRS): A method of assessment for use by nurses. Br J Psychiatry1980;137:558-565.
